Challenge
The biggest challenge faced by pharmaceutical companies worldwide is the time and cost involved in developing drugs in order for them to be approved.
Through tests we can see what the result of a drug is, but not necessarily the why – which protein does the drug target to get that result? This means that most developers are still using a trial and error method of testing. This results in a lot of time and money invested for low rates of approval. Hyperdrive Science has the solution.
Using technology that takes advantage of naturally occurring processes, Hyperdrive Science can target the specific protein related to the drug treatment, to make drug candidate selection more specific, thereby providing better, faster, and more relevant results. The rapid access to new target information of any drug candidate allows pharmaceutical companies to make more rational selections and unlock hidden value.